ERNICA is part of a joint working group with the European Reference Network for rare and complex urogenital diseases and conditions (eUROGEN) which is focused on anorectal malformations (ARM) and Hirschsprung Disease. eUROGEN is holding a webinar on Tuesday 20th October on the following topic: Newborn management of ARM in male patients. For further details and to register click here: https://attendee.gotowebinar.com/register/5183672168512470287
The September issue of the STEPS-EA newsletter is now available! Click here to read. The STEPS-EA trial is an ERNICA multi-centre Randomised Controlled Trial looking at intralesional STEroid injections to Prevent refractory Strictures in patients with Esophageal Atresia. The trial involves 1:1 randomization to injection with 10 mg/ml TAC (Kenacort-A 10) prior to balloon dilatation and balloon dilatation without any injection. This trial is in development. For any questions please email the STEPS-EA trial team at firstname.lastname@example.org
As of August 2020, ERNICA has officially welcomed all of its (17) new Affiliated Partner hospitals. You can read more about affiliated partnership and our affiliated partner centres here. Kepler University Hospital in Linz (Austria) celebrated their partnership with this ERNICA-shaped cake! Welcome to ERNICA - We are looking forward to collaborating with you all.